Regulatory
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Search
Who we are
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
NCF International
Regulatory
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Home
Politics & Business
Page 4
Politics & Business
Barriers to generic and biosimilar entry on the market
Giuliana Miglierini
-
25 November 2020
How the future of health systems may look like
Giuliana Miglierini
-
28 October 2020
How the pharmaceutical market will look like in 2026
Giuliana Miglierini
-
17 September 2020
Lessons learnt and preparedness for the second-wave pandemic
Giuliana Miglierini
-
28 August 2020
The technological agenda of the next EU Council’s presidencies
Giuliana Miglierini
-
22 July 2020
New market opportunities in the post-pandemic era
Giuliana Miglierini
-
18 June 2020
New M&A dynamics in an uncertain Covid-19 environment
Giuliana Miglierini
-
20 May 2020
The EU’s new Industrial and Pharmaceutical Strategies
Giuliana Miglierini
-
17 April 2020
The impact of Covid-19 on drug shortages
Giuliana Miglierini
-
26 March 2020
Affordability and innovation for sustainable access to medicines
Giuliana Miglierini
-
20 February 2020
1
...
3
4
5
...
7
Page 4 of 7
